Catalano C, Fraioli F, Laghi A, Napoli A, Pediconi F, Danti M, Nardis P, Passariello R
Department of Radiology, University of Rome La Sapienza, Viale Regina Elena 324, 00161 Rome, Italy.
AJR Am J Roentgenol. 2003 May;180(5):1271-7. doi: 10.2214/ajr.180.5.1801271.
The purpose of our study was to evaluate the accuracy of multidetector CT (MDCT) using a high-resolution protocol in the preoperative assessment of patients with renal cell carcinoma who are possible candidates for nephron-sparing surgery.
Forty patients with suspected renal cell carcinoma underwent MDCT. Contrast-enhanced acquisitions were obtained during arterial, nephrographic, and urographic phases using a thin-slice protocol. One-millimeter-thick source images were evaluated by two observers on a dedicated workstation for the identification and characterization of the tumor, presence of a pseudocapsule or invasion of perirenal fat, involvement of adrenal glands or surrounding tissues, presence of satellite lesions within Gerota's fascia, infiltration of renal vein and inferior vena cava, involvement of lymph nodes, and presence of distant metastases. Imaging findings were compared with surgical specimens using criteria from the Robson and TNM classification systems.
The presence and size of all lesions were correctly shown in all patients. In evaluating Robson stage I of renal cell carcinoma, we were able to diagnose fat infiltration on 1-mm scans with 96% sensitivity, 93% specificity, and 95% accuracy; the positive and negative predictive values were, respectively, 100% and 93%. One hundred percent accuracy was achieved in staging high-grade lesions.
High-resolution MDCT is accurate in the preoperative evaluation of patients with renal cell carcinoma.
我们研究的目的是评估使用高分辨率协议的多排螺旋CT(MDCT)在术前评估可能适合保留肾单位手术的肾细胞癌患者中的准确性。
40例疑似肾细胞癌患者接受了MDCT检查。使用薄层协议在动脉期、肾实质期和尿路造影期进行对比增强扫描。两位观察者在专用工作站上评估1毫米厚的源图像,以识别和表征肿瘤、假包膜的存在或肾周脂肪浸润、肾上腺或周围组织的受累情况、肾周筋膜内卫星灶的存在、肾静脉和下腔静脉的浸润、淋巴结受累情况以及远处转移的存在。使用罗布森和TNM分类系统的标准将影像学结果与手术标本进行比较。
所有患者中所有病变的存在和大小均被正确显示。在评估肾细胞癌的罗布森I期时,我们在1毫米扫描上诊断脂肪浸润的敏感度为96%、特异度为93%、准确度为95%;阳性和阴性预测值分别为100%和93%。在对高级别病变进行分期时达到了100%的准确度。
高分辨率MDCT在肾细胞癌患者的术前评估中是准确的。